Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01072188 · ClinicalTrials.gov registry record · Phase 3
Clinical Efficacy of 10% Arginine Bicarbonate Prophylaxis Paste
A Phase 3 study of Hypersensitivity, sponsored by Colgate Palmolive.
- Completed
- Registry status
- Phase 3
- Development phase
- 45
- Enrollment target
- 1
- Study location
NCT01072188 is a Phase 3 study of Hypersensitivity that has completed, run by Colgate Palmolive. The registered enrollment target is 45 participants, below the 179-participant average among 8 other Hypersensitivity trials with a reported enrollment target (75% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01072188, a Phase 3 study of Hypersensitivity, has completed, sponsored by Colgate Palmolive.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 45 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this study is to evaluate the clinical efficacy of a prophylaxis paste containing 10% arginine bicarbonate on dentinal hypersensitivity reduction when applied as a pre-procedure to a professional dental cleaning.
Conditions Studied
Interventions
- DEVICE Arginine/Calcium Carbonate
- DEVICE Nupro - Fluoride Free
Study Locations (1)
Pennsylvania
- Contract Dental Evaluations - Langhorne
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2008-07 |
| Est. Completion | 2008-08 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01072188
The ClinicalTrials.gov registry entry for NCT01072188 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 179-participant average among 8 other Hypersensitivity trials with a reported enrollment target (75% lower). The listed sponsor is Colgate Palmolive, which has 51 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Hypersensitivity appearing as the primary indexed condition, and to 2 interventions - of which Arginine/Calcium Carbonate is the first listed.
NCT01072188 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT01072188 about?
NCT01072188 is a clinical study titled "Clinical Efficacy of 10% Arginine Bicarbonate Prophylaxis Paste". The objective of this study is to evaluate the clinical efficacy of a prophylaxis paste containing 10% arginine bicarbonate on dentinal hypersensitivity reduction when applied as a pre-procedure to a professional dental cleaning.
What is the current status of trial NCT01072188?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 45 participants. The study started on 2008-07. Estimated completion is 2008-08.
What conditions does trial NCT01072188 study?
This clinical trial studies the following conditions: Hypersensitivity.
What interventions are being tested in trial NCT01072188?
The interventions under investigation include: Arginine/Calcium Carbonate (DEVICE), Nupro - Fluoride Free (DEVICE).
Who is sponsoring clinical trial NCT01072188?
This trial is sponsored by Colgate Palmolive, which has 51 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01072188 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hypersensitivity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Activation and Function of Eosinophils in Conditions With Blood or Tissue Eosinophilia
RECRUITING
-
Hybrid SA RGP Center/S-H Skirt Daily Wear 90 Day Multicenter Study
COMPLETED · NA
-
Omalizumab (Xolair) and Allergy Shots For the Treatment of Seasonal Allergies
COMPLETED · Phase 2
-
Oral Bacteria and Allergic Disease in Children
COMPLETED
-
Pilot Study to Investigate the Efficacy of a Toothpaste in Providing Relief From Dentinal Hypersensitivity
COMPLETED · NA
-
Phase II Efficacy Study of Aerosolized Recombinant Human IL-4 Receptor in Asthma
COMPLETED · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.